[Multimodal therapeutic strategies in the treatment of cerebrovascular disease].
A I FedinE N SaverskayaK R BadalyanPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
The review presents the scientific substantiation of the relationship between age-related cerebrovascular changes and dysregulation of cerebral perfusion, blood-brain barrier (BBB) function and neurovascular units. The ischemic cascade in cerebrovascular disease (CVD) is considered, the main links of which are glutamate excitoxicosis, oxidative stress and neuroinflammation. Endothelial dysfunction and increased BBB permeability play an important role in the development of neuroinflammation. The use of multifunctional drugs aimed at various pathological targets of acute and chronic cerebral ischemia for the purpose of neuroprotection has been substantiated. These drugs include the peptide Cortexin (cattle cerebral cortex polypeptides). Experimental data on the study of its molecular partners in the brain are presented. The clinical efficacy of Cortexin as a neuroprotective drug in CVD has been established in many studies.
Keyphrases
- cerebral ischemia
- blood brain barrier
- drug induced
- oxidative stress
- subarachnoid hemorrhage
- brain injury
- liver failure
- drug delivery
- dna damage
- electronic health record
- endothelial cells
- big data
- emergency department
- ischemia reperfusion injury
- cancer therapy
- contrast enhanced
- extracorporeal membrane oxygenation
- hepatitis b virus
- endoplasmic reticulum stress
- aortic dissection
- men who have sex with men
- hiv testing
- lps induced
- replacement therapy
- adverse drug